Bacterial Aptamer Screening Service

What is a Bacterial Aptamer Screening Service?

It is a specialized contract research service where a provider uses Systematic Evolution of Ligands by Exponential Enrichment (SELEX) to discover and develop single-stranded DNA or RNA aptamers that bind with high affinity and specificity to a bacterial target.

The target can be:

• Whole bacterial cells (e.g., E. coli O157:H7, Salmonella typhimurium).

• Specific bacterial components (e.g., surface proteins like pili, flagella, capsular polysaccharides, secreted toxins).

• Key virulence factors (e.g., endotoxins like LPS).

The resulting aptamers are powerful recognition elements for diagnostics, therapeutics, and research.

Core Steps in the Service Pipeline

A typical full-service offering includes:

1. Project Design & Target Preparation:

• Consultation: Defining the goal (e.g., detection of a specific strain, therapeutic neutralization).

• Target Choice: Deciding between whole cells (for broad detection) or purified components (for precise targeting).

• Counter-SELEX: Using related non-target cells (e.g., non-pathogenic strain) to eliminate cross-reactive aptamers and ensure specificity.

2. Library Synthesis & SELEX Process:

• Library Design: Using a random-sequence oligonucleotide library (typically ~10^14 different molecules).

• Selection Rounds (8-15 cycles): Iteratively incubating the library with the target, washing away unbound sequences, eluting the bound ones, and amplifying them via PCR (for DNA) or RT-PCR (for RNA).

• Monitoring: Using quantitative PCR or flow cytometry to track enrichment progress.

3. Next-Generation Sequencing (NGS) & Bioinformatics:

• Sequencing: High-throughput sequencing of the enriched pool from the final rounds.

• Bioinformatics Analysis: Identifying enriched sequence families, consensus motifs, and predicting secondary structures.

4. Aptamer Characterization & Validation:

• Synthesis & Truncation: Chemically synthesizing the lead candidate sequences and potentially truncating them to the minimal binding region.

• Affinity Measurement: Determining the dissociation constant (Kd) using techniques like surface plasmon resonance (SPR) or flow cytometry (typically aiming for nM to pM range).

• Specificity Testing: Validating against a panel of non-target bacteria.

• Functional Assays: Testing performance in the intended application (e.g., ELISA-style detection, inhibition of bacterial adhesion).

Key Deliverables from a Service Provider

• Characterized Aptamer Sequences: 2-5 lead candidate sequences with full binding data.

• Detailed Report: Comprehensive methodology, SELEX progression data, NGS analysis, and validation results.

• Binding Parameters: Kd values, specificity profiles, and optimal binding conditions.

• Physical Samples: Lyophilized or buffered aliquots of the validated aptamers.

Applications of the Resulting Aptamers

• Diagnostics: As capture/detection probes in biosensors, lateral flow assays, or microfluidic chips for rapid bacterial detection.

• Therapeutics: As neutralizing agents against toxins or as delivery vehicles to target antibiotics specifically to pathogens.

• Research Tools: For bacterial imaging, cell sorting, or studying host-pathogen interactions.

How to Choose a Service Provider: Critical Considerations

1. SELEX Platform Expertise: Do they specialize in Cell-SELEX (for whole bacteria)? Do they offer advanced methods like Capture-SELEX or Toggle-SELEX for complex targets?

2. Experience with Bacteria: Have they worked with similar bacterial targets (Gram-negative vs. Gram-positive, specific genera)? Handling live pathogens requires BSL-2+ facilities.

3. In-House NGS & Bioinformatics: Integrated sequencing and robust data analysis are crucial for efficient discovery.

4. Characterization Capabilities: Ensure they have SPR, BLI, or ITC for affinity measurement and flow cytometry for cell-based binding.

5. Turnaround Time & Cost: A full service typically takes 3-6 months and can range from $25,000 to $70,000+, depending on project complexity.

6. Intellectual Property (IP): Clearly define who owns the resulting aptamer sequences and any future licensing rights.

Examples of Service Providers

• Aptamer Group: Well-known for their proprietary Slow Off-rate Modified Aptamer (SOMAmer) platform, though more focused on proteins, they also handle complex targets.

• AptaDiscovery: Offers custom Cell-SELEX services with strong bioinformatics support.

• Base Pair Biotechnologies: Provides comprehensive custom aptamer discovery services, including bacterial targeting.

• Aptagen, LLC: Specializes in molecular recognition and offers custom aptamer development.

• Academic Core Facilities: Many university-based labs (e.g., in biomedical engineering or chemistry departments) offer collaborative or fee-for-service SELEX.